PRVA Privia Health Group Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 69
Relative Strength: Rel. Strength: 27
Relative Valuation: Rel. Valuation: 38
Relative Profitability: Rel. Profitability: 28

EPS in 2026 (TTM): $0.18

Last Report Period Date: Mar 31, 2026

As of June 2026, PRVA's trailing twelve months (TTM) EPS stands at $0.18, according to the latest financial reports. In 2025, the company recorded an earnings per share (EPS) of $0.19, which represents an increase compared to its EPS of $0.12 in 2024. PRVA reported an EPS of $0.02 for the quarterly report ending on Mar 31, 2026.

PRVA earnings history

Historical annual and quarterly earnings per share (EPS) data for Privia Health Group
EPS (TTM)
$0.18
EPS Growth YoY (Quarterly)
-33.3%
EPS (Quarterly)
$0.02
EPS Growth (Quarterly)
-75%

For 2025, Privia Health Group's EPS was $0.19, an increase of 58.3% from $0.12 in 2024. For the quarter ending Mar 31, 2026, the EPS was $0.02, showing a 33.3% decrease from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $0.18. In 2024, the annual EPS was $0.12, showing a decrease of 40% from 2023.

PRVA earnings chart

PRVA EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-33.3%
EPS growth YoY
58.3%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
-10.5%

Privia Health Group has recorded a decrease in EPS of 33.3% over the last 12 months (YoY, quarterly). Privia Health Group had an average annual EPS growth rate of -10.5% over the last 5 years.

PRVA Earnings Waterfall

Breakdown of revenue, profit and net income for Privia Health Group

All data is based on quarterly TTM periods, unless otherwise specified.